LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 51 filers reported holding LEGEND BIOTECH CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,190,078 | -17.9% | 32,605 | -15.6% | 0.00% | 0.0% |
Q2 2023 | $2,667,181 | +716.4% | 38,638 | +470.3% | 0.00% | – |
Q1 2023 | $326,691 | -70.3% | 6,775 | -74.9% | 0.00% | – |
Q3 2022 | $1,100,000 | +22.6% | 26,972 | +65.3% | 0.00% | – |
Q2 2022 | $897,000 | -79.5% | 16,313 | -86.5% | 0.00% | -100.0% |
Q1 2022 | $4,385,000 | +7.1% | 120,698 | +37.4% | 0.00% | – |
Q4 2021 | $4,094,000 | +625.9% | 87,822 | +687.1% | 0.00% | – |
Q3 2021 | $564,000 | -58.4% | 11,158 | -66.3% | 0.00% | – |
Q2 2021 | $1,357,000 | -63.8% | 33,086 | -74.4% | 0.00% | -100.0% |
Q1 2021 | $3,752,000 | +99.6% | 129,302 | +192.7% | 0.00% | +100.0% |
Q2 2020 | $1,880,000 | – | 44,171 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |